Abstract
At present, there are several advancements in the field of cancer treatment that promise to increase the lifespan of a cancer patient. However, cancer recurrence and drug resistance are the challenges still faced in the field of cancer treatment. The normal production of cellular reactive oxygen species (ROS) plays a pivotal role in maintaining the cell quiescence and metabolism of stem cells. Overproduction of ROS leads to cell proliferation, differentiation, and apoptosis in a dose-exposure manner. Cancer stem cells (CSCs) could self-renew and protect themselves from exposure to toxic chemicals and free radicals. ROS are induced by several signaling molecules, such as growth factors, Wnt, Notch, and Hedgehog pathways. Recent studies have also suggested that microRNAs (miRNAs) induce ROS production and activate various signaling cascades to induce cell proliferation in cancer cells. In addition, chemotherapy activates the overexpression of cancer miRNAs in tumor cells, which induces the epithelial to mesenchymal transition that leads to therapeutic resistance. In most of the malignant conditions, miRNAs enhance the expression of signaling pathways in CSCs and activate cell proliferation. In this review, we provide an update to ROS-mediated therapeutic resistance in the signaling pathways of CSCs.
Similar content being viewed by others
References
Aggarwal V et al (2019) Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements. Biomolecules 9(11):15471
Alpha-Tocopherol BCCPSG (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330(15):1029–1035
Bai XY et al (2011) miR-335 and miR-34a Promote renal senescence by suppressing mitochondrial antioxidative enzymes. J Am Soc Nephrol 22(7):1252–1261
Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3(7):730–737
Cannito S et al (2008) Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells. Carcinogenesis 29(12):2267–2278
Carew JS et al (2003) Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications. Leukemia 17(8):1437–1447
Chen CY et al (2007) Isokotomolide A, a new butanolide extracted from the leaves of Cinnamomum kotoense, arrests cell cycle progression and induces apoptosis through the induction of p53/p21 and the initiation of mitochondrial system in human non-small cell lung cancer A549 cells. Eur J Pharmacol 574(2–3):94–102
Chitty JL et al (2018) Recent advances in understanding the complexities of metastasis. F1000Res 7:F1000
Copin JC, Gasche Y, Chan PH (2000) Overexpression of copper/zinc superoxide dismutase does not prevent neonatal lethality in mutant mice that lack manganese superoxide dismutase. Free Radic Biol Med 28(10):1571–1576
Dando I et al (2015) Antioxidant mechanisms and ROS-related microRNAs in cancer stem cells. Oxidative Med Cell Longev 2015:425708
Dansen TB, Wirtz KW (2001) The peroxisome in oxidative stress. IUBMB Life 51(4):223–230
Dayem AA et al (2010) Role of oxidative stress in stem, cancer, and cancer stem cells. Cancers (Basel) 2(2):859–884
Dickinson BC, Chang CJ (2011) Chemistry and biology of reactive oxygen species in signaling or stress responses. Nat Chem Biol 7(8):504–511
Ding R et al (2016) The Hippo signalling pathway maintains quiescence in Drosophila neural stem cells. Nat Commun 7:10510
Duffey DC et al (2000) Inhibition of transcription factor nuclear factor-kappaB by a mutant inhibitor-kappaBalpha attenuates resistance of human head and neck squamous cell carcinoma to TNF-alpha caspase-mediated cell death. Br J Cancer 83(10):1367–1374
Eramo A et al (2008) Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15(3):504–514
Fath MA et al (2009) Mitochondrial electron transport chain blockers enhance 2-deoxy-D-glucose induced oxidative stress and cell killing in human colon carcinoma cells. Cancer Biol Ther 8(13):1228–1236
Gaston-Massuet C et al (2011) Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans. Proc Natl Acad Sci U S A 108(28):11482–11487
Goetz ME, Luch A (2008) Reactive species: a cell damaging rout assisting to chemical carcinogens. Cancer Lett 266(1):73–83
Gorrini C, Harris IS, Mak TW (2013) Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov 12(12):931–947
Haraguchi N et al (2010) CD13 is a therapeutic target in human liver cancer stem cells. J Clin Invest 120(9):3326–3339
Huang EH et al (2009) Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 69(8):3382–3389
Jin F et al (2019) The PI3K/Akt/GSK-3beta/ROS/eIF2B pathway promotes breast cancer growth and metastasis via suppression of NK cell cytotoxicity and tumor cell susceptibility. Cancer Biol Med 16(1):38–54
Kaemmerer E et al (2019) Targeting Wnt signaling via notch in intestinal carcinogenesis. Cancers (Basel) 11(4):555
Kennel KB, Greten FR (2021) Immune cell—produced ROS and their impact on tumor growth and metastasis. Redox Biol 42:101891
Keyvani-Ghamsari S et al (2021) Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance. Clin Epigenet 13(1):120
Kumari S et al (2018) Reactive oxygen species: a key constituent in cancer survival. Biomark Insights 13:1177271918755391
Lim SO et al (2008) Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Gastroenterology 135(6):2128–2140, 2140 e1-8
Lodygin D et al (2008) Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 7(16):2591–2600
Martinez NJ, Gregory RI (2010) MicroRNA gene regulatory pathways in the establishment and maintenance of ESC identity. Cell Stem Cell 7(1):31–35
Massague J, Obenauf AC (2016) Metastatic colonization by circulating tumour cells. Nature 529(7586):298–306
Maugeri-Sacca M, Vigneri P, De Maria R (2011) Cancer stem cells and chemosensitivity. Clin Cancer Res 17(15):4942–4947
Menendez JA, Alarcon T (2014) Metabostemness: a new cancer hallmark. Front Oncol 4:262
Mengqiu X, Ping W, Bei P, Junjie N, Shukui W, Bangshun H (2021) The diagnostic and prognostic values of MicroRNA-196a in cancer. Research square. https://doi.org/10.1042/BSR20203559
Muralikrishnan V, Hurley TD, Nephew KP (2020) Targeting aldehyde dehydrogenases to eliminate cancer stem cells in gynecologic malignancies. Cancers (Basel) 12(4):961
Nguyen CB, Houchen CW, Ali N (2017) APSA Awardee submission: tumor/cancer stem cell marker doublecortin-like kinase 1 in liver diseases. Exp Biol Med (Maywood) 242(3):242–249
Pan Z et al (2020) Role of microRNAs in remodeling the tumor microenvironment (review). Int J Oncol 56(2):407–416
Panchatcharam M et al (2006) Curcumin improves wound healing by modulating collagen and decreasing reactive oxygen species. Mol Cell Biochem 290(1–2):87–96
Park SA et al (2009) 4-hydroxyestradiol induces anchorage-independent growth of human mammary epithelial cells via activation of IkappaB kinase: potential role of reactive oxygen species. Cancer Res 69(6):2416–2424
Parkash J, Felty Q, Roy D (2006) Estrogen exerts a spatial and temporal influence on reactive oxygen species generation that precedes calcium uptake in high-capacity mitochondria: implications for rapid nongenomic signaling of cell growth. Biochemistry 45(9):2872–2881
Petrovic N et al (2007) CD13/APN regulates endothelial invasion and filopodia formation. Blood 110(1):142–150
Ruiz-Ramos R et al (2009) Sodium arsenite induces ROS generation, DNA oxidative damage, HO-1 and c-Myc proteins, NF-kappaB activation and cell proliferation in human breast cancer MCF-7 cells. Mutat Res 674(1–2):109–115
Rygiel TP et al (2008) The Rac activator Tiam1 prevents keratinocyte apoptosis by controlling ROS-mediated ERK phosphorylation. J Cell Sci 121(Pt 8):1183–1192
Saikolappan S et al (2019) Reactive oxygen species and cancer: a complex interaction. Cancer Lett 452:132–143
Sato A et al (2014) Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells. Stem Cell Res 12(1):119–131
Sattler UG et al (2010) Glycolytic metabolism and tumour response to fractionated irradiation. Radiother Oncol 94(1):102–109
Shen S et al (2010) ABCG2 reduces ROS-mediated toxicity and inflammation: a potential role in Alzheimer’s disease. J Neurochem 114(6):1590–1604
Sluijter JPG et al (2018) Extracellular vesicles in diagnostics and therapy of the ischaemic heart: position paper from the working group on Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 114(1):19–34
Sun H et al (1999) PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci U S A 96(11):6199–6204
Tamura K et al (2013) Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy. J Neurosurg 119(5):1145–1155
Thomas C et al (2009) Hydroxyl radical is produced via the Fenton reaction in submitochondrial particles under oxidative stress: implications for diseases associated with iron accumulation. Redox Rep 14(3):102–108
Turajlic S et al (2019) Resolving genetic heterogeneity in cancer. Nat Rev Genet 20(7):404–416
Ushio-Fukai M, Alexander RW (2004) Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol Cell Biochem 264(1–2):85–97
Vaghari-Tabari M et al (2020) MicroRNAs and colorectal cancer chemoresistance: new solution for old problem. Life Sci 259:118255
Valent P et al (2012) Cancer stem cell definitions and terminology: the devil is in the details. Nat Rev Cancer 12(11):767–775
Venugopal R, Jaiswal AK (1998) Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene 17(24):3145–3156
Verovskaya EV, Dellorusso PV, Passegue E (2019) Losing sense of self and surroundings: hematopoietic stem cell aging and leukemic transformation. Trends Mol Med 25(6):494–515
Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8(10):755–768
Wang M et al (2005) Manganese superoxide dismutase suppresses hypoxic induction of hypoxia-inducible factor-1alpha and vascular endothelial growth factor. Oncogene 24(55):8154–8166
Yang Z et al (2018) Identification of LETM1 as a marker of cancer stem-like cells and predictor of poor prognosis in esophageal squamous cell carcinoma. Hum Pathol 81:148–156
Yu J, Zhang L (2008) PUMA, a potent killer with or without p53. Oncogene 27(Suppl 1):S71–S83
Zhao H et al (2008) Protective effect of hyaluronate on oxidative DNA damage in WI-38 and A549 cells. Int J Oncol 32(6):1159–1167
Zhou D, Shao L, Spitz DR (2014) Reactive oxygen species in normal and tumor stem cells. Adv Cancer Res 122:1–67
Ziech D et al (2011) Reactive oxygen species (ROS)—induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res 711(1–2):167–173
Zucker SN et al (2014) Nrf2 amplifies oxidative stress via induction of Klf9. Mol Cell 53(6):916–928
Author Contributions
P.R. and S.J. wrote the manuscript. D.G. and K.P. edited the manuscript. All authors contributed to the article and approved the submitted version.
Funding
This study was supported by Department of Science and Technology (DST) Science Engineering Research Board (SERB), Government of India grant number EEQ/2017/000567 to KP.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2022 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Rajendran, P. et al. (2022). Cancer Stem Cells: Reactive Oxygen Species-Induced Drug Resistance in Cancer. In: Chakraborti, S. (eds) Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Springer, Singapore. https://doi.org/10.1007/978-981-16-1247-3_217-1
Download citation
DOI: https://doi.org/10.1007/978-981-16-1247-3_217-1
Received:
Accepted:
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-1247-3
Online ISBN: 978-981-16-1247-3
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences